On March 29, 2007, the FDA announced that manufacturers of pergolide drug products, which are used to treat Parkinson’s disease, will voluntarily remove these drugs from the market because of the risk of serious damage to patients’ heart valves. The products being withdrawn are Permax, the trade name for pergolide marketed by Valeant Pharmaceuticals, and two generic versions of pergolide manufactured by Par and Teva. Pergolide is in a class of medications called dopamine agonists and is used with levodopa and carbidopa to manage the symptoms (tremors and slowness of movement) of Parkinson’s disease.
Recent studies show that Permax and associated drugs increase the risk of valvular regurgitation. Valvular regurgitation is a condition where the valves malfunction and blood flows backwards causing the heart to enlarge and work harder. If left untreated, a patient can develop congestive heart failure and die. If the disease progresses enough, a patient can undergo surgery to replace or repair their heart valves.
If you or your loved ones took Permax or related drugs and had heart complications and or heart surgery, please call LT Pepper Law at 267.626.7546 for a free consultation.
Facebook Badge
About Me
- Luke T. Pepper
- Luke T. Pepper focuses his practice in the areas of Mass Torts, Class Actions, Environmental Liability,Securities Litigation, Medical Malpractice and Products Liability and Settlement Administration. He also represents businesses in various capacities. He was admitted to the bar in 2001 and is admitted to practice before the Pennsylvania state courts, and the U.S. District Court for the Eastern District of Pennsylvania
No comments:
Post a Comment